Home
Market Capitalization of Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Ltd
NSE: ASPIRAPATHLAB
Market Cap
Key Highlights
- The Market Cap of Aspira Pathlab & Diagnostics Ltd is ₹ 67.82 crore as of 21 Feb 25 .
- The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 65.89 as of 21 Feb 15:30 .

Aspira Pathlab & Diagnostics Ltd
NSE: ASPIRAPATHLAB
Share Price
Market Price of Aspira Pathlab & Diagnostics Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 65.89 |
20 Feb 2025 | 64.6 |
19 Feb 2025 | 63.34 |
18 Feb 2025 | 62.1 |
17 Feb 2025 | 63.36 |
14 Feb 2025 | 64.65 |
13 Feb 2025 | 65.96 |
11 Feb 2025 | 67.3 |
10 Feb 2025 | 67.3 |
07 Feb 2025 | 68.67 |
SWOT Analysis Of Aspira Pathlab & Diagnostics Ltd
BlinkX Score for Aspira Pathlab & Diagnostics Ltd
Asset Value vs Market Value of Aspira Pathlab & Diagnostics Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Aspira Pathlab & Diagnostics Ltd
Historical P/E Ratio of Aspira Pathlab & Diagnostics Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Aspira Pathlab & Diagnostics Ltd
Historical Revenue of Aspira Pathlab & Diagnostics Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Aspira Pathlab & Diagnostics Ltd
Historical EBITDA of Aspira Pathlab & Diagnostics Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Aspira Pathlab & Diagnostics Ltd
Historical Net Profit of Aspira Pathlab & Diagnostics Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Aspira Pathlab & Diagnostics Ltd
Dividend Payout Over Time
About Aspira Pathlab & Diagnostics Ltd
- Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
- ASDL is a leading pathology specialist, with Pan-India presence.
- It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
- The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
- Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. During the year, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'.
Aspira Pathlab & Diagnostics Ltd News Hub
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.02 crore in the June 2024 quarter
Net Loss of Aspira Pathlab & Diagnostics reported to Rs 0.02 crore in the quarter ended June 2024 as
Read more
14 Aug 24
Aspira Pathlab & Diagnostics to announce Quarterly Result
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 13 Augu
Read more
05 Aug 24
Aspira Pathlab & Diagnostics AGM scheduled
Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the company will be
Read more
28 Aug 24
Aspira Pathlab & Diagnostics schedules board meeting
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 Nove
Read more
30 Oct 24